# Services offered by the Vaccine Evaluation and Development Centre (VDEC)

Source: https://www.keypedia.com/records/uk_mhra_guidance/uk-mhra/d42c3eef-bd63-42f1-9c8a-d659abdb9663
Type: Detailed Guide
Published: May 19, 2024
Updated: July 16, 2024

> We use decades of experience in safe bioagent handling to support partners in research, development and testing of vaccines and therapeutics

---

## Content

Our VDEC services The Vaccine Development and Evaluation Centre ( VDEC ) supports scientists at every stage of the vaccine and therapeutic medicine development process. Our services are accredited to ISO 9001:2015, good laboratory practice ( GLP ) good clinical practice ( GCP ) or good manufacturing practice ( GMP ) quality standards as appropriate. Work with VDEC We work with industry, academia and government. Contact UKHSA today to see how we can help you. Get in touch Our working areas Discovery and surveillance bacterial and viral isolation preparation of characterised bacterial and viral stocks antigen discovery for novel and emerging viruses and bacterial pathogens recombinant protein expression, purification and characterisation antimicrobial discovery and evaluation See more information about our discovery services . Antimicrobial resistance ( AMR ) preventing AMR arising during treatment combating or reversing existing drug resistance reducing drug toxicity and treatment times tackling multidrug-resistant gram-negative infections See more information about our AMR services . Pre-clinical pre-clinical in vivo model development for infectious diseases pathogen challenge models, protective efficacy studies and immunogenicity testing advanced imaging including MRI in-life PET-CT and CT scanning organ-on-a-chip or micro-physiological systems research pathology and histopathology services medical countermeasure testing provision of data for regulatory submissions See more information about our pre-clinical services . Clinical development, characterisation and validation of immuno assays for clinical evaluation (Phase I-III) virus neutralisation and pseudovirus assays, enzyme-linked immunosorbent assays ( ELISAs ), multiplexed and functional cell-based assays high throughput serology assays for emerging pathogens provision of data for regulatory submissions See more information about our clinical services . Post-licensure phase IV study support provision of data for regulatory submissions See more information about our post-licensure services . Other services biosafety and infection control services high-containment laboratory and outbreak response training Scientist conducting an immunoassay Who we work with We work collaboratively with partners in government academic institutes non-governmental organisation ( NGO ) funding bodies life science companies